1. Takao Kato, Hidenori Yaku, Yasutaka Inuzuka, YodoTamaki, Erika Yamamoto, Takeshi Kimura. Impact of decreased lymphocyte total cholesterol and albumin levels at discharge on all-cause death in patients with acute heart failure.
ACC Asia 2021 Together With SCS 32nd Annual Scientific Meeting Virtual July 9-11, 2021, web
1. Takao Kato, Eisaku Nakane, Tetsuya Haruna, Moriaki Inoko. Mitochondrial Structural Abnormalities are Common Features in the Myocardium of Patients with Various Types of Cardiomyopathy.
Central America and the Caribbean Multidisciplinary Symposium on Comprehensive Anticoagulation approach 2021 July 16, 2021, web
Eri Toda Kato. Anticoagulation therapy for AF in the Elderly: overcoming fears.
ESC Congress 2021 – The Digital Experience August 27-30, 2021, web
Takao Kato, M. Momose, Y. Uemura, M. Naya, N. Matsumoto, S. Hida, T. Yamauchi, T. Nakajima, E. Suzuki, M. Inoko, N. Tamaki. Association of the extent of myocardial ischemia with outcomes in patients with suspected coronary artery disease in Japan: a cohort study.
Takao Kato, H. Yaku, E. Yamamoto, Y. Inuzuka, Y. Tamaki, N. Ozasa, T. Kimura. Impact of decreased lymphocyte, total cholesterol, and albumin levels at discharge on all-cause death in patients with acute heart failure.
Hirotoshi Watanabe, T. Morimoto, M. Natsuaki, K. Yamamoto, Y. Obayashi, S. Suwa, T. Isawa, H. Watanabe, H. Tokuyama, H. Sakamoto, H. Suzuki, K. Wakabayashi, K. Ando, K. Kadota, T. Kimura, for the STOPDAPT-2 ACS investigators. One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome: STOPDAPT-2 ACS.
Yugo Yamashita, Takeshi Morimoto, Takeshi Kimura. Autoimmune disorders and venous thromboembolism: A report from the COMMAND VTE Registry.
Yugo Yamashita, Hidewo Amano, Takeshi Morimoto, Takeshi Kimura. Risk Factors of Recurrence and Major Bleeding in Patients with Intermediate-risk for Recurrence of Venous Thromboembolism: From the COMMAND VTE Registry.
Yuta Seko, T. Kato, T. Morimoto, H. Yaku, Y. Inuzuka, Y. Tamaki, N. Ozasa, M. Shiba, E. Yamamoto, Y. Yoshikawa, Y. Yamashita, T. Kitai, K. Kuwahara, T. Kimura. Starting Neurohormonal Antagonists in Patients with Acute Heart Failure with Mid-Range and Preserved Ejection Fraction.
2021 TSOC Annual Convention & Scientific Session – JCS-TSOC online hybrid joint session Aug 28, 2021, Web
1. Hirotoshi Watanabe. Optimal Antiplatelet Treatment of ACS and CCS in High Bleeding Risk Patients.
The 10th International Congress on Lipid & Atherosclerosis (ICoLA2021) September 11, 2021, Korea
1. Koh Ono. Function of miR-33a/b in lipid and systemic metabolism.
AHA Hypertension Scientific Sessions 2021 September 27–29, 2021, web
Takao Kato, Eri Minamino-Muta, Moriaki Inoko. Hypertensive Disorders of Pregnancy and Increased Levels of Cardiac Troponin I after Delivery.
The 19th International Symposium on Atherosclerosis (ISA 2021) October 24–27, 2021, web・Kyoto
Koh Ono. Elucidation of the role of miR-33a/b in atherosclerosis and obesity. Contrast between central and peripheral roles.
Osamu Baba. The CCR2 targeting peptide-based PET tracer, 64Cu-DOTA-ECL1i can non-invasively visualize monocytes and inflammatory macrophages in atherosclerotic plaque.
Great Wall International Congress of Cardiology October 27–31, 2021, web
Koh Ono. Function of microRNA-33a/b in atherosclerosis-related diseases and systemic metabolism.
TCT 2021 November 4-6, 2021, Orlando, Florida・web
Yuki Obayashi, Ko Yamamoto , Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, Takenori Domei, Kyohei Yamaji, Satoru Suwa, Tsuyoshi Isawa, Hiroki Watanabe, Ruka Yoshida, Hiroki Sakamoto, Masaharu Akao, Yoshiki Hata, Itsuro Morishima, Hideo Tokuyama, Masahiro Yagi, Hiroshi Suzuki, Kohei Wakabayashi, Nobuhiro Suematsu, Tsukasa Inada, Toshihiro Tamura, Hideki Okayama, Mitsuru Abe, Kazuya Kawai, Koichi Nakao, Kenji Ando, Kengo Tanabe, Yuji Ikari, Yoshihiro Morino, Kazushige Kadota, Yutaka Furukawa, Yoshihisa Nakagawa, and Takeshi Kimura. STOPDAPT-2 Total Cohort: Pooled Results From Two Randomized Trials of Clopidogrel Monotherapy After 1-Month DAPT Following PCI According to ACS Presentation and Ischemic and Bleeding Risk.
American Heart Association’s annual Scientific Sessions 2021 November 13-15, 2021, Boston・web
Takao Kato. Prognostic Implications Of Coronary Revascularization With Diagnostic Imaging Tests.
Erika Yamamoto, Takao Kato, Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Yukihito Sato, Koichiro Kuwahara and Takeshi Kimura. Influence of Worsening Heart Failure During Hospitalization on the Prognosis in Patients with Acute Decompensated Heart Failure.
Koichi Washida, Takao Kato, Neiko Ozasa, Takeshi Morimoto, Hidenori Yaku, Yuta Seko, Erika Yamamoto, Yusuke Yoshikawa, Yugo Yamashita and Takeshi Kimura. Risk Factors And Clinical Outcomes Of Non-home Discharge In Patients With Acute Decompensated Heart Failure: An Observational Study.
Yuta Tsujisaka, Takeshi Hatani, Kenji Miki, Takeshi Kimura, Hirohide Saito, Yoshinori Yoshida. Isolation of Matured Human iPSC-derived Ventricular Cardiomyocytes using Synthetic MicroRNA Switch.
Eri Muta, Takao Kato, Tomohiko Taniguchi, Takeshi Kimura. Differences In Prognostic Implications Of Changes In Echocardiography In Asymptomatic Severe Aortic Stenosis Managed Conservatively.
Ohno M, Shiomi H, Yano M, Aizawa T, Nakano Y, Yamagami S, Kato M, Ohya M, Chen P-M, Nagao K, Ando K, Kadota K, Yokomatsu T, Inada T, Kurokawa M, Morimoto T, Kimura T, Nishi E. Nardilysin is a Potential Biomarker for the Early Diagnosis of Non-St-Segment Elevation Acute Coronary Syndrome, A Multicenter Prospective Cohort Study, Nardi-ACS Study.
ESC Asia 2021 with APSC & AFC December 2-4, 2021, web